Literature DB >> 10681351

Intravitreal, retinal, and central nervous system foscarnet concentrations after rapid intravenous administration to rabbits.

L F López-Cortés1, R Ruiz-Valderas, M J Lucero-Muñoz, E Cordero, M T Pastor-Ramos, J Marquez.   

Abstract

Retinal, vitreous humor, brain, and cerebrospinal fluid (CSF) foscarnet levels were measured by high-performance liquid chromatography after administration of an intravenous dose of 120 mg/kg of body weight to 32 pigmented rabbits. A pharmacokinetic analysis was done using a two-compartment model. The penetration ratios, defined as ratios of retinal, vitreous humor, brain, and CSF areas under the concentration-time curve from 0 to 2 h were 110% +/- 1%, 12.3% +/- 0.7%, 118% +/- 1%, and 20.2% +/- 2.2%, respectively. These results suggest a good penetration of foscarnet into the retinal and brain tissues, reaching higher concentrations than those estimated from vitreous humor and CSF levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681351      PMCID: PMC89759          DOI: 10.1128/AAC.44.3.756-759.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Management of varicella zoster virus retinitis in AIDS.

Authors:  R S Moorthy; D V Weinberg; S A Teich; B B Berger; J T Minturn; S Kumar; N A Rao; S M Fowell; I A Loose; L M Jampol
Journal:  Br J Ophthalmol       Date:  1997-03       Impact factor: 4.638

2.  Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients.

Authors:  A M Taburet; C Katlama; C Blanshard; G Zorza; D Gazzard; E Dohin; B G Gazzard; C Frostegard; E Singlas
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

3.  Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals.

Authors:  W L Drew; R Miner; E Saleh
Journal:  Clin Diagn Virol       Date:  1993-08

4.  A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS.

Authors:  M A Jacobson; D Causey; B Polsky; D Hardy; M Chown; R Davis; J J O'Donnell; B D Kuppermann; M H Heinemann; G N Holland
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

Review 5.  Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.

Authors:  P Chrisp; S P Clissold
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

6.  Penetration of foscarnet into cerebrospinal fluid of AIDS patients.

Authors:  F Raffi; A M Taburet; B Ghaleh; A Huart; E Singlas
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

7.  Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis.

Authors:  U R Hengge; N H Brockmeyer; R Malessa; U Ravens; M Goos
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

8.  Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives.

Authors:  R G Dacey; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

Review 9.  Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.

Authors:  R Nau; F Sörgel; H W Prange
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

10.  Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection.

Authors:  J Sjövall; S Bergdahl; G Movin; S Ogenstad; M Saarimäki
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

View more
  2 in total

Review 1.  Advances in the management of acute retinal necrosis.

Authors:  Jessica G Shantha; Heather M Weissman; Matthew R Debiec; Thomas A Albini; Steven Yeh
Journal:  Int Ophthalmol Clin       Date:  2015

2.  Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluid.

Authors:  Marija Djukic; Martin Munz; Fritz Sörgel; Ulrike Holzgrabe; Helmut Eiffert; Roland Nau
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.